Biomarkers of everolimus efficacy in breast cancer therapy
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Oncology Pharmacy Practice"
DOI: 10.1177/10781552211073673
Abstract: Objective Everolimus is an inhibitor of serine/ threonine kinase mTOR. The drug is approved for the treatment of metastatic ER positive, HER2 negative breast cancers and benefits a subset of patients with these breast cancers… read more here.
Keywords: breast cancer; breast; efficacy breast; everolimus efficacy ... See more keywords
Efficacy of breast cancer screening program in Kingdom of Saudi Arabia.
Sign Up to like & getrecommendations! Published in 2022 at "Saudi medical journal"
DOI: 10.15537/smj.2022.43.4.20210823
Abstract: the early stages of BC through screening, especially in the high-risk population. We suggest transforming the read more here.
Keywords: screening program; program kingdom; breast cancer; kingdom saudi ... See more keywords